Marketplace has a new podcast for kids, "Million Bazillion!" EPISODE OUT NOW

Site funds study of brain tumor drug

Janet Babin May 17, 2010
HTML EMBED:
COPY

Site funds study of brain tumor drug

Janet Babin May 17, 2010
HTML EMBED:
COPY

by Janet Babin

Pharmaceutical companies routinely spend more than $1 billion to bring a new drug to market. Drug patents help them recoup their investment — giving them a temporary monopoly.

But DCA is a cheap generic that’s been around for more than 30 years. The patent’s long gone. Companies have no economic incentive to study its potential to fight cancer.

So Dr. Evangelos Michelakis, a professor at the University of Alberta, set up a website to fund the research through public donations.

“We had people that sent a $10-dollar check and we had people that sent a $3,000 check — from Siberia, New Zealand, Africa, South America, the States,” says Dr. Michelakis.

Dr. Michelakis says donations paid for 90 percent of the study, which cost about $1 million. He’s asking the public to fund a second, larger clinical trial.

We’re here to help you navigate this changed world and economy.

Our mission at Marketplace is to raise the economic intelligence of the country. It’s a tough task, but it’s never been more important.

In the past year, we’ve seen record unemployment, stimulus bills, and reddit users influencing the stock market. Marketplace helps you understand it all, will fact-based, approachable, and unbiased reporting.

Generous support from listeners and readers is what powers our nonprofit news—and your donation today will help provide this essential service. For just $5/month, you can sustain independent journalism that keeps you and thousands of others informed.